Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

WTO head says pandemic-related trade barriers are rising

Published 06/14/2021, 10:07 AM
Updated 06/14/2021, 10:12 AM
© Reuters. FILE PHOTO: Vials labelled "AstraZeneca, Pfizer - Biontech, Johnson&Johnson, Sputnik V coronavirus disease (COVID-19) vaccine" are seen in this illustration picture taken May 2, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

© Reuters. FILE PHOTO: Vials labelled "AstraZeneca, Pfizer - Biontech, Johnson&Johnson, Sputnik V coronavirus disease (COVID-19) vaccine" are seen in this illustration picture taken May 2, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

By Emma Farge

GENEVA (Reuters) -The head of the World Trade Organization said on Monday that trade barriers related to medical supplies used against COVID-19 had risen and urged member states to drop them, as it intensified efforts to reach a deal on vaccine-sharing.

"The trend is going in the wrong direction," WTO Director General Ngozi Okonjo-Iweala told a virtual U.N. forum, referring to barriers on goods trade related to the pandemic.

"We need to bring those restrictions down so we can move ... medical goods and supplies and vaccines (faster)."

She said the number of trade restrictions reported by WTO member states was 109 at the start of the pandemic early last year, and had later fallen to 51 but had since risen to 53, without giving a time-frame.

One such measure is the European Union's export authorisation scheme for COVID-19 vaccines, which is set to expire on 30 June. Okonjo-Iweala has previously said she is "disappointed" by the scheme although the Commission has said it is targeted, proportionate and temporary.

Another way to ease trade flows might be a "voluntary monitoring system" to identify and remove supply bottlenecks, she added, saying the WTO was in talks with manufacturers and the International Chamber of Commerce and other partners about setting this up.

At the same event, she called on WTO members to reach a deal by July on improving access to COVID-19 vaccines after months of talks on waiving drug firms' intellectual property rights. Most developing countries support the waiver but several wealthy countries remain strongly opposed, saying it will deter research that allowed COVID-19 vaccines to be produced so quickly.

© Reuters. FILE PHOTO: Vials labelled

"I'm in a hurry and I want us to get some agreement by July because lives are important," Okonjo-Iweala said.

The former Nigerian finance minister also commented on a WTO ministerial conference next month that will aim to strike a deal on cutting fisheries subsidies, saying she still saw "serious differences" between countries.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.